Funder
National Basic Research Program of China
National Natural Science Foundation of China
National Natural Science Foundation of Guangxi
Project for cultivating High-level Talent Teams
Qi Huang Project of Guang Xi University of Chinese Medicine
Intrgrative Medicine and School research projects
Reference19 articles.
1. Synthesis, crystallization, and biological evaluation of an orally active prodrug of Gemcitabine;Bender;J. Med. Chem.,2009
2. Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma;Eckel;Cancer Investigation,2003
3. Efficacy of low-dose oral metronomic dosing of the prodrug of Gemcitabne, LY2334737, in human tumor xenografts;Pratt;Mol. Cancer Ther.,2013
4. Intestinal drug transporters: an overview;Estudante;Adv. Drug Deliv. Rev.,2012
5. Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral Gemcitabine prodrug, in patients with advanced solid tumors;Faivre;Invest. New Drugs,2015
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献